Occurrence of Cranial Neoplasms in Pediatric Patients with Noonan Syndrome Receiving Growth Hormone: Is Screening with Brain MRI prior to Initiation of Growth Hormone Indicated?
- PMID: 28746941
- PMCID: PMC9204260
- DOI: 10.1159/000479107
Occurrence of Cranial Neoplasms in Pediatric Patients with Noonan Syndrome Receiving Growth Hormone: Is Screening with Brain MRI prior to Initiation of Growth Hormone Indicated?
Abstract
Noonan syndrome (NS) is associated with short stature. Growth hormone treatment has been FDA approved for use in these patients. Children with NS are at a higher risk of developing benign and malignant proliferative disorders, primary brain tumors being one of them. Since growth hormone therapy can worsen the tumor burden, screening with a brain MRI prior to growth hormone initiation in NS patients is strongly recommended. Here we present two NS patients who developed different primary brain tumors while being on growth hormone therapy.
Keywords: Brain tumors; Growth hormone; Noonan syndrome.
© 2017 S. Karger AG, Basel.
Conflict of interest statement
Disclosure Statement
All authors have no disclosures/conflict of interest except as mentioned below: Oscar Escobar served as a member of an Advisory Board meeting for Versartis, Inc.
Figures
References
-
- Fryssira H, Leventopoulos G, Psoni S, KitsiouTzeli S, Stavrianeas N, Kanavakis E: Tumor development in three patients with Noonan syndrome. Eur J Pediatr 2008; 167:1025–1031. - PubMed
-
- Perry JK, Emerald BS, Mertani HC, Lobie PE: The oncogenic potential of growth hormone. Growth Horm IGF Res 2006; 16:277–289. - PubMed
-
- Schuettpelz LG, McDonald S, Whitesell K, Desruisseau DM, Grange DK, Gurnett CA, Wilson DB: Pilocytic astrocytoma in a child with Noonan syndrome. Pediatr Blood Cancer 2009; 53:1147–1149. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
